Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma

NCT00002634 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: monoclonal antibody 3F8
DRUG: cisplatin
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: mesna
DRUG: perfosfamide
DRUG: vincristine sulfate
PROCEDURE: autologous bone marrow transplantation
PROCEDURE: in vitro-treated bone marrow transplantation
RADIATION: low-LET cobalt-60 gamma ray therapy
RADIATION: low-LET photon therapy
RADIATION: radioisotope therapy

Sponsor

Memorial Sloan Kettering Cancer Center